Holyoake, T L and Allan, E K and Mountford, J C and Richmond, L and Harrison, S J and Elliott, M A and Jorgensen, H G (2003) Pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line K562. Blood, 102 (11). 654A-654A. ISSN 0006-4971Full text not available in this repository. (Request a copy from the Strathclyde author)
Meeting abstract 2420 looks at pre-treatment with bryostatin or lonafirnib improves the efficacy of imatinib against G0/G1 cells in the Ph+ cell line, K562.
|Keywords:||pre-treatment, bryostatin, lonafirnib, efficacy, imatinib , G0/G1, ph+ cell line, Pharmacy and materia medica, Biochemistry, Cell Biology, Immunology, Hematology|
|Subjects:||Medicine > Pharmacy and materia medica|
|Department:||Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences|
|Depositing user:||Pure Administrator|
|Date Deposited:||21 Nov 2011 14:39|
|Last modified:||04 Dec 2016 01:05|